FDA Approval of Axi-Cel - 42% of patients have long-term durability - 101931

Spotlight
Video

FDA Approval of Axi-Cel - 42% of patients have long-term durability

ASHReport has 256 videos Subscribe Here

Loading........
Description: Sattva S. Neelapu, MD from MD Anderson Cancer Center discusses FDA's approval of Axi-Cel and 42% of patients have long-term durability at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/15/18
Added : 8 months ago
Category : Lymphoma